[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:fredrickson-type-v-lipidemia":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Fredrickson Type V Lipidemia",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07491172","A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias",[11],"Phase 1","RECRUITING","2026-08-26T02:18:15.214990Z","2026-05-05T02:43:29.073051Z",[],[]]